These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18622504)

  • 1. [Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].
    Rubin AS; Souza FJ; Hetzel JL; Moreira Jda S
    J Bras Pneumol; 2008 Jun; 34(6):373-9. PubMed ID: 18622504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
    Celli BR; Tashkin DP; Rennard SI; McElhattan J; Martin UJ
    Respir Med; 2011 Aug; 105(8):1176-88. PubMed ID: 21531124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
    Molimard M; Bourcereau J; Le Gros V; Bourdeix I
    Respir Med; 2005 Jun; 99(6):695-702. PubMed ID: 15878485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.
    Wadbo M; Löfdahl CG; Larsson K; Skoogh BE; Tornling G; Arweström E; Bengtsson T; Ström K;
    Eur Respir J; 2002 Nov; 20(5):1138-46. PubMed ID: 12449166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
    Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
    Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized study.
    Cote C; Pearle JL; Sharafkhaneh A; Spangenthal S
    Pulm Pharmacol Ther; 2009 Feb; 22(1):44-9. PubMed ID: 19071226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
    Benhamou D; Cuvelier A; Muir JF; Leclerc V; Le Gros V; Kottakis J; Bourdeix I
    Respir Med; 2001 Oct; 95(10):817-21. PubMed ID: 11601748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.
    Derom E; Strandgården K; Schelfhout V; Borgström L; Pauwels R
    Respir Med; 2007 Sep; 101(9):1931-41. PubMed ID: 17544264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
    Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
    Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD.
    De Backer W; De Backer J; Vos W; Verlinden I; Van Holsbeke C; Clukers J; Hajian B; Siddiqui S; Jenkins M; Reisner C; Martin UJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2673-2684. PubMed ID: 30214185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.
    Quinn D; Seale JP; Reisner C; Fischer T; Golden M; Fernandez C; Darken P; St Rose E; Thomas M; Tardie G; Orevillo C
    Respir Med; 2014 Sep; 108(9):1327-35. PubMed ID: 25060541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.
    Aalbers R; Ayres J; Backer V; Decramer M; Lier PA; Magyar P; Malolepszy J; Ruffin R; Sybrecht GW
    Eur Respir J; 2002 May; 19(5):936-43. PubMed ID: 12030736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
    Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD.
    La Piana GE; Corda L; Bertella E; Montemurro LT; Pini L; Tantucci C
    Int J Chron Obstruct Pulmon Dis; 2011; 6():399-405. PubMed ID: 21857779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study.
    Whale CI; Sovani MP; Mortimer KJ; Harrison TW; Tattersfield AE
    Br J Clin Pharmacol; 2008 Jun; 65(6):841-7. PubMed ID: 18394012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.